Hydrophilic Domain II of Escherichia coli Dr Fimbriae Facilitates Cell Invasion
暂无分享,去创建一个
P. Urvil | J. Kur | B. Nowicki | S. Nowicki | V. Popov | S. Lea | A. Samet | D. Pettigrew | S. Matthews | P. Goluszko | K. L. Anderson | Margaret Das | Audrey Hart-Van Tassell
[1] Pietro Roversi,et al. High Resolution Studies of the Afa/Dr Adhesin DraE and Its Interaction with Chloramphenicol* , 2004, Journal of Biological Chemistry.
[2] Pietro Roversi,et al. An atomic resolution model for assembly, architecture, and function of the Dr adhesins. , 2004, Molecular cell.
[3] Bogdan Nowicki,et al. Urinary tract infection in pregnant women: Old dogmas and current concepts regarding pathogenesis , 2002, Current infectious disease reports.
[4] Mathura S Venkatarajan,et al. Structure-Function Analysis of Decay-Accelerating Factor: Identification of Residues Important for Binding of the Escherichia coli Dr Adhesin and Complement Regulation , 2002, Infection and Immunity.
[5] Betsy Foxman,et al. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. , 2002, The American journal of medicine.
[6] E. Sokurenko,et al. The Major Structural Subunits of Dr and F1845 Fimbriae Are Adhesins , 2002, Infection and Immunity.
[7] S. Lea. Interactions of CD55 with non-complement ligands. , 2001, Biochemical Society transactions.
[8] R. Selvarangan,et al. Rapid Receptor-Clustering Assay To Detect Uropathogenic and Diarrheal Escherichia coli Isolates Bearing Adhesins of the Dr Family , 2001, Journal of Clinical Microbiology.
[9] S. Abraham,et al. Glycosylphosphatidylinositol-anchored receptor-mediated bacterial endocytosis. , 2001, FEMS microbiology letters.
[10] R. Selvarangan,et al. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. , 2001, The Journal of infectious diseases.
[11] B. Finlay,et al. Microbial pathogenesis: Lipid rafts as pathogen portals , 2000, Current Biology.
[12] J. Nataro,et al. Characterization of the AfaD‐like family of invasins encoded by pathogenic Escherichia coli associated with intestinal and extra‐intestinal infections , 2000, FEBS letters.
[13] R. Selvarangan,et al. Role of Decay-Accelerating Factor Domains and Anchorage in Internalization of Dr-Fimbriated Escherichia coli , 2000, Infection and Immunity.
[14] E. Johnsson,et al. Human complement regulators: a major target for pathogenic microorganisms. , 2000, Current opinion in immunology.
[15] R. Powell,et al. Crystallization and preliminary X-ray diffraction analysis of a biologically active fragment of CD55. , 1999, Acta crystallographica. Section D, Biological crystallography.
[16] S. Schappert,et al. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.
[17] D. Shafren. Viral Cell Entry Induced by Cross-Linked Decay-Accelerating Factor , 1998, Journal of Virology.
[18] B. Nowicki,et al. Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor , 1997, Infection and immunity.
[19] A. Labigne,et al. Adhesion to and invasion of HeLa cells by pathogenic Escherichia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively , 1997, Infection and immunity.
[20] R. Selvarangan,et al. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. , 1997, The Journal of infectious diseases.
[21] N. Hibler,et al. Arrest of Mycobacterial Phagosome Maturation Is Caused by a Block in Vesicle Fusion between Stages Controlled by rab5 and rab7* , 1997, The Journal of Biological Chemistry.
[22] L. Truong,et al. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis. , 1997, The Journal of clinical investigation.
[23] S. Moseley,et al. Mutational analysis of receptor binding mediated by the Dr family of Escherichia coli adhesins , 1997, Molecular microbiology.
[24] C. Bloch,et al. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. , 1995, The Journal of infectious diseases.
[25] J. Bergelson,et al. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[26] B. Nowicki,et al. Short consensus repeat-3 domain of recombinant decay-accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction , 1993, The Journal of experimental medicine.
[27] A. Miettinen,et al. Binding of bacterial adhesins to rat glomerular mesangium in vivo. , 1993, Kidney international.
[28] S. Moseley,et al. Molecular structure of the Dr adhesin: nucleotide sequence and mapping of receptor-binding domain by use of fusion constructs , 1991, Infection and immunity.
[29] Richard,et al. The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition , 1990, Infection and Immunity.
[30] B. Nowicki,et al. A hemagglutinin of uropathogenic Escherichia coli recognizes the Dr blood group antigen , 1988, Infection and immunity.
[31] L. Truong,et al. Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. , 1988, The American journal of pathology.
[32] B. Nowicki,et al. Molecular cloning of the Escherichia coli O75X adhesin , 1987, Infection and immunity.
[33] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.